Citation Impact
Citing Papers
Endocrine Disruptors and Asthma-Associated Chemicals in Consumer Products
2012 Standout
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
2009 StandoutScience
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Gabapentin: a multimodal perioperative drug?
2007
Capsaicin (TRPV1 Agonist) Therapy for Pain Relief
2008
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Nicotine Chemistry, Metabolism, Kinetics and Biomarkers
2009 Standout
Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
2008
Distance delivery of mindfulness-based cognitive therapy for depression: Project UPLIFT
2010
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
2009 Standout
Antioxidant capacity of the neurohormone melatonin
2005
Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials
2003
Natural products: An evolving role in future drug discovery
2011 Standout
Computer-based psychological treatments for depression: A systematic review and meta-analysis
2012 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
2004
A meta-analysis of 25 years of mood-creativity research: Hedonic tone, activation, or regulatory focus?
2008 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions
2014
Drug Glucuronidation in Clinical Psychopharmacology
2001
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Clinical approaches to treatment of Internet addiction
2014 Standout
The Absolute Bioavailability of Oral Melatonin
2000
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
Mood Disorders in Patients with Epilepsy
2002
Intracranial cortical localization of the human K-complex
2010
Clinically relevant drug interactions with antiepileptic drugs
2005
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Pharmacokinetics and Pharmacodynamics of Sedatives and Analgesics in the Treatment of Agitated Critically Ill Patients
1997
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Vigabatrin for tuberous sclerosis complex
2001
Tuberous sclerosis
2008 Standout
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Epilepsy and quality of life in adults: A review of instruments
2005
Persistent postsurgical pain: risk factors and prevention
2006 Standout
Effectiveness of Muscimol‐containing Microparticles against Pilocarpine‐induced Focal Seizures
2002
Calorie restriction in rhesus monkeys
2003
Melatonin as a natural ally against oxidative stress: a physicochemical examination
2011 Standout
Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life
2010
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Spinal Dorsal Horn Calcium Channel α2δ-1 Subunit Upregulation Contributes to Peripheral Nerve Injury-Induced Tactile Allodynia
2004
Effects of mindfulness on psychological health: A review of empirical studies
2011 Standout
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
2013 Standout
A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice
2008
Epilepsy and cognition
2003
Multiple dose gabapentin attenuates cutaneous pain and central sensitisation but not muscle pain in healthy volunteers
2006
International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels
2005 Standout
Myoclonus: current concepts and recent advances
2004
Chiral Toxicology: It's the Same Thing…Only Different
2009
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Gabapentin inhibits high‐threshold calcium channel currents in cultured rat dorsal root ganglion neurones
2002
Painful Diabetic Polyneuropathy
2011
One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species?
2006 Standout
Recent advances in the study on capsaicinoids and capsinoids
2010 Standout
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
A Mechanistic Approach to Antiepileptic Drug Interactions
1998
Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids
2015
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Physiological Basis of Transcranial Direct Current Stimulation
2011 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
Antiepileptic drugs and apoptotic neurodegeneration in the developing brain
2002
About Sleep's Role in Memory
2013 Standout
Diabetic Somatic Neuropathies
2004 Standout
Delay-dependent modulation of memory retrieval by infusion of a dopamine D₁ agonist into the rat medial prefrontal cortex.
2001
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian.
2009
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
2006 Standout
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Barry E. Gidal being referenced
Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs
2002
Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy
2000
Evaluation of the Effect of Fluoxetine on the Formation of Carbamazepine Epoxide
1993
Current Developments in Neurology, Part II: Advances in the Pharmacotherapy of Alzheimer Disease, Parkinson's Disease, and Stroke
1996
Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy
1998
Lorazepam‐Valproate Interaction: Studies in Normal Subjects and Isolated Perfused Rat Liver
1994
Antiepileptic Drug Interactions
2000
Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy
2003
Melatonin: Therapeutic Use in Sleep Disorders
1997
Sleep Architecture in Children with Idiopathic Generalized Epilepsy
2005
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability
2000
New and emerging treatment options for neuropathic pain.
2006
Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression.
1999
Vigabatrin: A Novel Therapy for Seizure Disorders
1999
Intravenous valproic acid for myoclonic status epilepticus
2000
Use of Gabapentin in the Treatment of Neuropathic Pain
2000